Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-059648
Filing Date
2020-05-11
Accepted
2020-05-11 17:11:50
Documents
59
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2014597d1_10q.htm 10-Q 768381
2 EXHIBIT 31.1 tm2014597d1_ex31-1.htm EX-31.1 12544
3 EXHIBIT 31.2 tm2014597d1_ex31-2.htm EX-31.2 12505
4 EXHIBIT 32.1 tm2014597d1_ex32-1.htm EX-32.1 5086
5 EXHIBIT 32.2 tm2014597d1_ex32-2.htm EX-32.2 5018
  Complete submission text file 0001104659-20-059648.txt   4268403

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mbio-20200331.xml EX-101.INS 969792
7 XBRL TAXONOMY EXTENSION SCHEMA mbio-20200331.xsd EX-101.SCH 39040
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbio-20200331_cal.xml EX-101.CAL 42736
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbio-20200331_def.xml EX-101.DEF 155565
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbio-20200331_lab.xml EX-101.LAB 299299
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbio-20200331_pre.xml EX-101.PRE 268217
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

EIN.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38191 | Film No.: 20865986
SIC: 2834 Pharmaceutical Preparations